series-b
Stage
1
Investors
About
Larkspur Biosciences develops first-in-class targeted protein degraders that disrupt cancer cell survival by degrading key stress-response pathways essential for tumor fitness.
Explore Larkspur's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.